Global & Disaster Medicine

A midseason glimpse of flu vaccine effectiveness (VE) in Canada shows that protection against the H3N2 strain is very low, similar to what Australian scientists reported in the fall

Eurosurveillance

“….As reported from Australia for the 2017 southern hemisphere vaccine, interim estimates from Canada for the 2017/18 northern hemisphere vaccine indicate low VE of less than 20% against influenza A(H3N2), notably among working-age adults. While the influenza A(H3N2) epidemic continues, adjunct protective measures should be reinforced to minimise the associated disease burden in high-risk individuals….”


Comments are closed.

Categories

Recent Posts

Archives

Admin